β-Adrenergic blocker. Prepn: H. Ruschig et al., ZA 6807915; eidem, US 3551493 (1969, 1970 both to Hoechst). Preliminary chemistry and pharmacology: G. H"artfelder et al., Arzneim.-Forsch. 22, 930 (1972). Physicochemical and analytical study: P. Hajdu, D. Damm, ibid. 29, 602 (1979). Pharmacology: J. Kaiser et al., ibid. 30, 420 (1980). Action specificity: J. Kaiser ibid. 427. Crystallographic study: J. M. Leger et al., Mol. Pharmacol. 17, 339 (1980). Hemodynamic effects: P. Lund-Johansen, Eur. J. Clin. Pharmacol. 16, 149 (1979). Clinical study in hypertension: J. L. Cangiano et al., J. Clin. Pharmacol. 19, 384 (1979). HPLC determn in plasma: R. K. Bhamra et al., Biomed. Chromatogr. 1, 140 (1986). Review of pharmacology and therapeutic efficacy: R. C. Heel et al., Drugs 22, 1-25 (1981).
Antihypertensive; antianginal; antiarrhythmic.
β-Adrenergic Blocker; Antianginal; Antiarrhythmic; Antihypertensive; Aryloxypropanolamine Derivatives